Health
Study reports highly potent anti-SARS-CoV-2 compounds – News-Medical.Net
A new study published on the preprint server bioRxiv in July 2020 reports that a series of potent enzyme inhibitors have been designed to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication by interfering with one of the primary …
A new study published on the preprint server bioRxiv* in July 2020 reports that a series of potent enzyme inhibitors have been designed to suppress severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication by interfering with one of the primary viral proteases. The authors urge rapid clinical and preclinical testing of their most potent compounds to meet the need for an effective antiviral therapeutics for the ongoing pandemic of COVID-19.
Introduction to the Viral Polyprotein Pr…
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General21 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General18 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General11 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore